Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
boston top stories
crispr-cas9
editas medicine
3
×
life sciences
national blog main
national top stories
san francisco blog main
3
×
san francisco top stories
biotech
crispr
crispr therapeutics
gene editing
intellia therapeutics
national
advaxis
agios therapeutics
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
andrew oxtoby
babies
base editing
boston
boulder/denver blog main
boulder/denver top stories
branden moriarty
breakup
bridge bio pharma
broad institute
cancer
cas13
ceo
clinical hold
clinical study
combination
commissioner
congress
david liu
delisting
What
cas
3
×
crispr
medicine
editas
editing
gene
beam
big
bio
bosley's
bosley’s
bridge
bucks
cancer
cells
ceo
crime
defect
departure
drive
edited
editor
exit
fears
flag
founders
genetic
gotten
guardian
guiding
harvard
human
jump
katrine
known
lab
malfunction
mass
moves
nature
Language
Current search:
cas
×
" editas medicine "
×
" boston blog main "
×
" san francisco blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
6 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M